Reviewed Company Q3 30/09/2019 Unable to reach any conclusion with an emphasis of matters 2019 Reviewed Consolidated Q3 30/09/2019 Unable to reach any conclusion with an emphasis of matters 2019 Reviewed
Statement MD&A Financial Statement Revise 2020 Reviewed Company Q2 30/06/2020 Unable to reach any conclusion with an emphasis of matters /Others 2020 Reviewed Consolidated Q2 30/06/2020 Unable to reach
Statement MD&A Financial Statement Revise 2020 Reviewed Company Q3 30/09/2020 2020 Reviewed Consolidated Q3 30/09/2020 2020 Reviewed Company Q2 30/06/2020 Unable to reach any conclusion with an
opinion with an emphasis of matters 2019 Reviewed Company Q3 30/09/2019 Unable to reach any conclusion with an emphasis of matters 2019 Reviewed Consolidated Q3 30/09/2019 Unable to reach any conclusion
and the operating results of the Company for the year ended 31 December 2019. The conclusion was detailed as follows: The Company's operating results for the year 2019, had a net profit of 17.2 million
. The conclusion was as follows: Overview of the business group in Q2/2019 The Company operates as a holding company and invests in businesses related to the retail and consumer finance, which have a
and discuss with the Stock Exchange of Thailand (the “SET”) and the Securities and Exchange Commission, to seek for the conclusion of whether the Company needs to propose the transaction of providing
gained revenue solely from the medical equipment sales because the dialysis facility had been under construction. The dialysis has been manufactured and distributed around that end of July 2017, resulting